Dashboard
Manage Tickers

AZTR Azitra, Inc.

NYSE azitrainc.com


$ 0.59 $ 0.05 (8.45 %)    

Friday, 24-Oct-2025 15:45:02 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.83 $ 1.85 (0.3 %)
DIA $ 472.36 $ 2.50 (0.53 %)
SPY $ 677.67 $ 1.19 (0.18 %)
TLT $ 91.46 $ -0.10 (-0.11 %)
GLD $ 377.57 $ -1.00 (-0.26 %)
$ 0.5444
$ 0.56
$ 0.58 x 2
$ 0.60 x 333
$ 0.55 - $ 0.62
$ 0.50 - $ 4.33
437,176
na
1.92M
$ -29.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 02-24-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-12-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-15-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

azitra-to-present-preclinical-progress-for-atr-01-program-targeting-treatment-of-ichthyosis-vulgaris-at-bio-europe-conference
Azitra To Present Preclinical Progress For...
10/20/2025 12:10:24

ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis vulgarisPreclin...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/20/2025 12:08:17

azitra-receives-non-compliance-letter-from-nyse-american
Azitra Receives Non-Compliance Letter From...
10/03/2025 20:46:48

crude-oil-gains-over-1-up-fintech-shares-plunge
Crude Oil Gains Over 1%; UP Fintech Shares...
08/27/2025 18:35:56

dow-surges-over-100-points-jm-smucker-earnings-miss-views
Dow Surges Over 100 Points; JM Smucker Ear...
08/27/2025 14:38:23

azitra-doses-first-patient-in-phase-12-trial-of-atr04-484-for-egfri-associated-rash
Azitra Doses First Patient In Phase 1/2 Tr...
08/27/2025 12:11:25

Azitra, Inc. ("Azitra") (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therap...

stock-market-today-dow-sp-500-futures-rise-as-wall-street-awaits-powells-jackson-hole-keynoteazitra-zoom-among-top-movers-updated
Stock Market Today: Dow, S&P 500 Futures R...
08/22/2025 12:51:09

U.S. stock futures rose on Friday following Thursday's declines. Futures of major benchmark indices were higher.

why-epicquest-education-shares-are-trading-higher-by-over-81-here-are-20-stocks-moving-premarket
Why EpicQuest Education Shares Are Trading...
08/22/2025 12:01:17

why-azitra-stock-shot-up-59-after-hours
Why Azitra Stock Shot Up 59% After-Hours?
08/22/2025 04:25:07

Azitra shares surged over 58% after hours following a reverse stock split and new institutional ownership disclosure by Alumni ...

azitra-executes-1-for-666-reverse-stock-split-effective-aug-21-common-shares-to-trade-on-adjusted-basis-following-shareholder-approved-amendment
Azitra Executes 1-For-6.66 Reverse Stock S...
08/20/2025 20:40:06

- SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 12:08:34

anitra-q2-eps-018-beats-021-estimate
Anitra Q2 EPS $(0.18) Beats $(0.21) Estimate
08/11/2025 21:08:48

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/11/2025 21:06:28

azitra-announces-1-for-666-reverse-stock-split
Azitra Announces 1-For-6.66 Reverse Stock ...
08/11/2025 20:22:31

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/17/2025 12:08:52

azitra-reports-safety-data-from-phase-1b-trial-of-atr12-351-netherton-syndrome-says-atr12-351-has-been-generally-safe-and-well-tolerated-with-occasional-transient-mild-to-moderate-symptoms-at-application-site
Azitra Reports Safety Data From Phase 1b T...
06/17/2025 12:03:47

azitra-to-highlight-recent-updates-and-progress-in-its-pipeline-including-atr-12-currently-in-phase-1b-clinical-trial-in-adult-patients-with-netherton-syndrome-and-atr-04-at-2025-bio-international-convention
Azitra To Highlight Recent Updates And Pro...
06/10/2025 12:37:39

azitra-to-present-data-highlighting-phase-12-clinical-trial-of-atr04-484-in-egfr-inhibitor-associated-rash-at-2025-asco-annual-meeting
Azitra To Present Data Highlighting Phase ...
05/28/2025 12:38:18

Azitra, Inc. (NYSE:AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision d...

azitra-to-present-phase-12-study-of-atr04-484-for-egfr-inhibitor-associated-rash
Azitra To Present Phase 1/2 Study Of ATR04...
05/14/2025 20:11:35

Azitra plans to dose first patient in a Phase 1/2 trial in the first half of 2025 for its precision dermatology candidate ATR04...

anitra-q1-eps-023-up-from-432-yoy
Anitra Q1 EPS $(0.23) Up From $(4.32) YoY
05/13/2025 21:08:46

Anitra (AMEX:AZTR) reported quarterly losses of $(0.23) per share. This is a 94.68 percent increase over losses of $(4.32) per ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION